Giorgos Aristotelous

This study reveals that Graves’ disease patients exhibit distinct gut microbiota signatures, with increased Bacteroidetes and Prevotellaceae and decreased Firmicutes and Lachnospiraceae, strongly associated with thyroid function markers. These microbial shifts may play a role in GD pathogenesis and serve as potential clinical biomarkers.

This study identified distinctive alterations in gut microbiota in Graves’ disease, including reduced diversity and specific taxonomic shifts. Key microbial signatures correlated with thyroid autoimmunity, highlighting potential diagnostic biomarkers and suggesting that microbiome modulation may offer new therapeutic avenues for Graves’ disease.

This study reveals that Chinese Graves’ disease patients exhibit reduced gut microbiota diversity and distinct compositional changes, with specific genera correlating to disease markers. Anti-thyroid therapy partially restores microbiome diversity, suggesting gut microbial signatures may serve as biomarkers or therapeutic targets in Graves’ disease.

This study demonstrates that gut microbiome composition and function differ significantly between Graves’ disease and Graves’ orbitopathy, with specific taxa correlating with thyroid autoimmunity. These findings highlight the potential of gut microbial markers for distinguishing GO from GD and understanding disease mechanisms.

This study found that Graves’ disease is associated with reduced gut microbial diversity and specific increases in Bacilli, Lactobacillales, Prevotella, Megamonas, and Veillonella, alongside decreases in Ruminococcus, Rikenellaceae, and Alistipes, identifying a distinctive intestinal microbiota signature relevant to GD pathogenesis.

What was studied? This case–control observational study investigated the associations between peripheral blood cytokine profiles and gut microbiota composition in patients with Graves’ disease (GD), the most common autoimmune thyroid disorder. The study aimed to elucidate the interplay between immune dysregulation—specifically changes in cytokines such as interleukin-10 (IL-10), transforming growth factor β (TGF-β), and interleukin-17A […]

This study found that a structured exercise program in euthyroid Graves’ disease patients improved aerobic capacity, reduced fatigue, normalized some thyroid hormones, accelerated anti-thyroid medication withdrawal, and reduced relapse rates, highlighting exercise’s clinical and potential immunological benefits.

This systematic review found insufficient evidence to confirm that physical exercise reduces endometriosis risk or symptoms, though some data suggest a potential protective effect. Well-designed controlled trials are needed to clarify the role of exercise in endometriosis prevention and management.

This review found that physical activity and exercise significantly improved pain, emotional well-being, and perceived control in women with endometriosis, supporting their use as safe and effective complementary therapies.